Clinical relevance of immunogenicity: an interview with Arno Kromminga

Bioanalysis Zone recently interviewed Dr. Arno Kromminga, European Chief Scientific Officer of BioAgilytix’s Hamburg location, to discuss his background in immunogenicity and gather his insights around the best methods for assessing immunogenicity and their associated advantages and disadvantages; what he sees as the greatest challenges in immunogenicity today; and his predictions for the future of immunogenicity.

Click for full article
Share This